rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
1994-8-5
|
pubmed:abstractText |
We report islet hyperplasia, nesidioblastosis, and abundant islet amyloidosis (derived from islet amyloid polypeptide) in a case of severe insulin resistance due to a circulating antiinsulin receptor antibody. Massive chronic beta-cell stimulation (as well as noninsulin-dependent diabetes mellitus and insulinoma) appears to be associated with islet amyloid.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0021-972X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
79
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
290-2
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:8027243-Amyloid,
pubmed-meshheading:8027243-Amyloidosis,
pubmed-meshheading:8027243-Autoantibodies,
pubmed-meshheading:8027243-Humans,
pubmed-meshheading:8027243-Immunohistochemistry,
pubmed-meshheading:8027243-Insulin Resistance,
pubmed-meshheading:8027243-Islet Amyloid Polypeptide,
pubmed-meshheading:8027243-Islets of Langerhans,
pubmed-meshheading:8027243-Male,
pubmed-meshheading:8027243-Middle Aged,
pubmed-meshheading:8027243-Pancreatic Diseases,
pubmed-meshheading:8027243-Receptor, Insulin,
pubmed-meshheading:8027243-Ubiquitins
|
pubmed:year |
1994
|
pubmed:articleTitle |
Islet amyloidosis in a patient with chronic massive insulin resistance due to antiinsulin receptor antibodies.
|
pubmed:affiliation |
Endocrine Research Unit, Mayo Clinic, Rochester, Minnesota 55905.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Case Reports,
Research Support, Non-U.S. Gov't
|